Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).
The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.
Two major ferry companies have decided to stop shipping animals used in preclinical drug development to the UK, prompting concerns about the future of the country’s research sector.
Draft EU GDP guidelines would “significantly increase” supply-chain costs and be “virtually impossible” to carry out, big pharma and logistics companies said.
Lonza has denied reports it has signed a deal with the South African government to build a $210m (€159m) API plant, saying it is merely “in discussions” over plans.
inVentiv Health says it will now offer a one-stop-shop for pharma and biotech training services after merging its subsidiaries Pharmaceutical Institute and Preceptiv Learning Solutions.
Securing supply chains and limiting access to manufacturing data can help stop clinical-stage drugs being abused in sport according to UK drug major GSK.
State-border delays, tolls and paperwork are increasing logistics costs in India and making transit less efficient than the EU and China, a report found.
SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.
Electronic contract manufacturer Distron Corporation is poised to expand its business when it cuts the ribbon on a newly expanded production facility today.
Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
CROs and CMOs reluctant to integrate simulation and forecasting into clinical supply strategies are missing out on significant financial benefits according to BioClinica and Paragon Solutions.
By Lee S. Scheible, RPh., CA-AM and Jeffrey S Kasher, PhD
Sponsors need to abandon the ‘single trial, random, tactical sourcing approach’ in favour of a model flexible enough for a variety of study designs and research needs according to Eli Lilly experts Lee Scheible and Jeffrey S Kasher in this exclusive guest...
Prefilled injection systems specialist Vetter has completed structural work on its new facility in Erlen, Germany, eleven months after ground-breaking.
A new direct flight between London Heathrow and San Diego from 1st June 2011 will benefit the international biotech sector according to UK-based Biotec Services International.
Supply chain services firm Tracelink says that half of Catalent Pharma Solutions’ US manufacturing sites have been added to its network under the strategic partnership signed last summer.
FedEx has launched a new shipping service for temperature sensitive products, specifically designed for customers in the life science and biopharma industries.
NextPharma Technologies will be bought by Sun European Partners, the European adviser to US investment group Sun Capital Partners, in a deal announced late yesterday.
United Parcel Service (UPS) will open four global healthcare distribution centres to accommodate its fast growing healthcare business and a rising global customer base.
Australian Pharmaceutical Industries (API) and Sigma Pharmaceuticals shares’ have been hit by Pfizer’s decision to abandon wholesale distributors in favour of selling drugs direct to pharmacies.
Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...
